News & Events about Beyondspring Inc.
Additional analyses of non-small cell lung cancer (NSCLC) studies support the efficacy of plinabulin monotherapy in reducing the mean duration of severe neutropenia (DSN) for patients receiving docetaxelIn an analysis of breast cancer patients, plinabulin monotherapy was superior vs no treatment for...
Thinking about buying stock in Nio, Redbox Entertainment, Agora, Chromadex, or Beyondspring? Thinking about buying stock in Nio, Redbox Entertainment, Agora, Chromadex, or Beyondspring? PR Newswire NEW YORK, June 10, 2022 NEW YORK, June 10, 2022 /PRNewswire/ --InvestorsObserverissues critical...
Globe Newswire
8 months ago
NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company or BeyondSpring) (NASDAQ: BYSI), a clinical stage global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes for patients who have a high unmet medical need, today announced...
Globe Newswire
8 months ago
Paul Friel
Elevar Therapeutics today announced the hiring of Paul Friel as chief commercial officer.
SALT LAKE CITY, May 23, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who ...
Globe Newswire
9 months ago
NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company or BeyondSpring) (Nasdaq: BYSI), a clinical stage global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes for patients who have high unmet medical needs, today ...